APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dulaglutide Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dulaglutide Injection Industry Growth and Trends Forecast to 2032

26 December 202574 pages

Choose your research edition.

Industry ResearchDulaglutide Injection Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Dulaglutide Injection Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dulaglutide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dulaglutide Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dulaglutide Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dulaglutide Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dulaglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dulaglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dulaglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dulaglutide Injection include Eli Lilly and Company and Boan Biotech among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dulaglutide Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dulaglutide Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dulaglutide Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dulaglutide Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dulaglutide Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dulaglutide Injection Market by Company

Eli Lilly and Company

Boan Biotech

Dulaglutide Injection Segment by Type

0.75 mg/0.5 mL

1.5 mg/0.5 mL

3 mg/0.5 mL

4.5 mg/0.5 mL

Dulaglutide Injection Segment by Application

Adults

Children

Dulaglutide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dulaglutide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dulaglutide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dulaglutide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dulaglutide Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dulaglutide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.75 mg/0.5 mL Table 2. Major Company of 1.5 mg/0.5 mL Table 3. Major Company of 3 mg/0.5 mL Table 4. Major Company of 4.5 mg/0.5 mL Table 5. Global Dulaglutide Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 7. Global Dulaglutide Injection Sales Market Share in Volume by Type (2021-2026) Table 8. Global Dulaglutide Injection Sales by Type (2021-2026) & (US$ Million) Table 9. Global Dulaglutide Injection Sales Market Share in Value by Type (2021-2026) Table 10. Global Dulaglutide Injection Price by Type (2021-2026) & (US$/Unit) Table 11. Global Dulaglutide Injection Sales by Type (2027-2032) & (K Units) Table 12. Global Dulaglutide Injection Sales Market Share in Volume by Type (2027-2032) Table 13. Global Dulaglutide Injection Sales by Type (2027-2032) & (US$ Million) Table 14. Global Dulaglutide Injection Sales Market Share in Value by Type (2027-2032) Table 15. Global Dulaglutide Injection Price by Type (2027-2032) & (US$/Unit) Table 16. North America Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 17. North America Dulaglutide Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 19. Europe Dulaglutide Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Dulaglutide Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 23. Latin America Dulaglutide Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Dulaglutide Injection Sales by Type (2021-2026) & (US$ Million) Table 26. Dulaglutide Injection Industry Trends Table 27. Dulaglutide Injection Industry Drivers Table 28. Dulaglutide Injection Industry Opportunities and Challenges Table 29. Dulaglutide Injection Industry Restraints Table 30. Global Dulaglutide Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Dulaglutide Injection Revenue Market Share by Company (2021-2026) Table 32. Global Dulaglutide Injection Sales by Company (2021-2026) & (K Units) Table 33. Global Dulaglutide Injection Sales Share by Company (2021-2026) Table 34. Global Dulaglutide Injection Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Dulaglutide Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Dulaglutide Injection Major Company Production Sites and Headquarters Table 37. Global Dulaglutide Injection Company, Product Type & Application Table 38. Global Dulaglutide Injection Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Dulaglutide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Dulaglutide Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Dulaglutide Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Dulaglutide Injection Sales Market Share in Volume by Region (2021-2026) Table 44. Global Dulaglutide Injection Sales by Region (2021-2026) & (US$ Million) Table 45. Global Dulaglutide Injection Sales Market Share in Value by Region (2021-2026) Table 46. Global Dulaglutide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Dulaglutide Injection Sales by Region (2027-2032) & (K Units) Table 48. Global Dulaglutide Injection Sales Market Share in Volume by Region (2027-2032) Table 49. Global Dulaglutide Injection Sales by Region (2027-2032) & (US$ Million) Table 50. Global Dulaglutide Injection Sales Market Share in Value by Region (2027-2032) Table 51. Global Dulaglutide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Dulaglutide Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 54. Global Dulaglutide Injection Sales Market Share in Volume by Application (2021-2026) Table 55. Global Dulaglutide Injection Sales by Application (2021-2026) & (US$ Million) Table 56. Global Dulaglutide Injection Sales Market Share in Value by Application (2021-2026) Table 57. Global Dulaglutide Injection Price by Application (2021-2026) & (US$/Unit) Table 58. Global Dulaglutide Injection Sales by Application (2027-2032) & (K Units) Table 59. Global Dulaglutide Injection Sales Market Share in Volume by Application (2027-2032) Table 60. Global Dulaglutide Injection Sales by Application (2027-2032) & (US$ Million) Table 61. Global Dulaglutide Injection Sales Market Share in Value by Application (2027-2032) Table 62. Global Dulaglutide Injection Price by Application (2027-2032) & (US$/Unit) Table 63. North America Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 64. North America Dulaglutide Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 66. Europe Dulaglutide Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Dulaglutide Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 70. Latin America Dulaglutide Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Dulaglutide Injection Sales by Application (2021-2026) & (US$ Million) Table 73. Eli Lilly and Company Company Information Table 74. Eli Lilly and Company Business Overview Table 75. Eli Lilly and Company Dulaglutide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Eli Lilly and Company Dulaglutide Injection Product Portfolio Table 77. Eli Lilly and Company Recent Development Table 78. Boan Biotech Company Information Table 79. Boan Biotech Business Overview Table 80. Boan Biotech Dulaglutide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Boan Biotech Dulaglutide Injection Product Portfolio Table 82. Boan Biotech Recent Development Table 83. North America Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 84. North America Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 85. North America Dulaglutide Injection Sales Market Share by Country (2021-2026) Table 86. North America Dulaglutide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 87. North America Dulaglutide Injection Sales Market Share Forecast by Country (2027-2032) Table 88. North America Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Dulaglutide Injection Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Dulaglutide Injection Market Share by Country (2021-2026) Table 91. North America Dulaglutide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Dulaglutide Injection Market Share Forecast by Country (2027-2032) Table 93. Europe Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 94. Europe Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 95. Europe Dulaglutide Injection Sales Market Share by Country (2021-2026) Table 96. Europe Dulaglutide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 97. Europe Dulaglutide Injection Sales Market Share Forecast by Country (2027-2032) Table 98. Europe Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Dulaglutide Injection Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Dulaglutide Injection Market Share by Country (2021-2026) Table 101. Europe Dulaglutide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Dulaglutide Injection Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 105. Asia-Pacific Dulaglutide Injection Sales Market Share by Country (2021-2026) Table 106. Asia-Pacific Dulaglutide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 107. Asia-Pacific Dulaglutide Injection Sales Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Dulaglutide Injection Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Dulaglutide Injection Market Share by Country (2021-2026) Table 111. Asia-Pacific Dulaglutide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Dulaglutide Injection Market Share Forecast by Country (2027-2032) Table 113. Latin America Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Latin America Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 115. Latin America Dulaglutide Injection Sales Market Share by Country (2021-2026) Table 116. Latin America Dulaglutide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 117. Latin America Dulaglutide Injection Sales Market Share Forecast by Country (2027-2032) Table 118. Latin America Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Dulaglutide Injection Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Dulaglutide Injection Market Share by Country (2021-2026) Table 121. Latin America Dulaglutide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Dulaglutide Injection Market Share Forecast by Country (2027-2032) Table 123. Middle East and Africa Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Middle East and Africa Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 125. Middle East and Africa Dulaglutide Injection Sales Market Share by Country (2021-2026) Table 126. Middle East and Africa Dulaglutide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 127. Middle East and Africa Dulaglutide Injection Sales Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Dulaglutide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Dulaglutide Injection Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East and Africa Dulaglutide Injection Market Share by Country (2021-2026) Table 131. Middle East and Africa Dulaglutide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Dulaglutide Injection Market Share Forecast by Country (2027-2032) Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Dulaglutide Injection Distributors List Table 136. Dulaglutide Injection Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Dulaglutide Injection Image Figure 2. Global Dulaglutide Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dulaglutide Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Dulaglutide Injection Sales (2021-2032) & (K Units) Figure 5. 0.75 mg/0.5 mL Image Figure 6. Global 0.75 mg/0.5 mL Sales YoY Growth (2021-2032) & (K Units) Figure 7. 1.5 mg/0.5 mL Image Figure 8. Global 1.5 mg/0.5 mL Sales YoY Growth (2021-2032) & (K Units) Figure 9. 3 mg/0.5 mL Image Figure 10. Global 3 mg/0.5 mL Sales YoY Growth (2021-2032) & (K Units) Figure 11. 4.5 mg/0.5 mL Image Figure 12. Global 4.5 mg/0.5 mL Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Dulaglutide Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Dulaglutide Injection Market Share by Type 2025 VS 2032 Figure 15. North America Dulaglutide Injection Sales Market Share in Volume by Type in 2025 Figure 16. North America Dulaglutide Injection Sales Market Share in Value by Type in 2025 Figure 17. Europe Dulaglutide Injection Sales Market Share in Volume by Type in 2025 Figure 18. Europe Dulaglutide Injection Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Dulaglutide Injection Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Dulaglutide Injection Sales Market Share in Value by Type in 2025 Figure 21. Latin America Dulaglutide Injection Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Dulaglutide Injection Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Dulaglutide Injection Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Dulaglutide Injection Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Dulaglutide Injection Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 29. Children Image Figure 30. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Dulaglutide Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Dulaglutide Injection Market Share by Application 2025 VS 2032 Figure 33. North America Dulaglutide Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Dulaglutide Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Dulaglutide Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Dulaglutide Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Dulaglutide Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Dulaglutide Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Dulaglutide Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Dulaglutide Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Dulaglutide Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Dulaglutide Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Dulaglutide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Dulaglutide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Dulaglutide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Dulaglutide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dulaglutide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Dulaglutide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Dulaglutide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Dulaglutide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dulaglutide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Dulaglutide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Dulaglutide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Dulaglutide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dulaglutide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Dulaglutide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Dulaglutide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Dulaglutide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dulaglutide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Dulaglutide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Dulaglutide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Dulaglutide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Dulaglutide Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Dulaglutide Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.75 mg/0.5 mL
  • 1.5 mg/0.5 mL
  • 3 mg/0.5 mL
  • 4.5 mg/0.5 mL
Applications
  • Adults
  • Children
Companies covered
  • Eli Lilly and Company
  • Boan Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dulaglutide Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dulaglutide Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dulaglutide Injection Market by Type
  6. 1.3.1 0.75 mg/0.5 mL
  7. 1.3.2 1.5 mg/0.5 mL
  8. 1.3.3 3 mg/0.5 mL
  9. 1.3.4 4.5 mg/0.5 mL
  10. 1.4 Global Dulaglutide Injection Market Size by Type
  11. 1.4.1 Global Dulaglutide Injection Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Dulaglutide Injection Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Dulaglutide Injection Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Dulaglutide Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Dulaglutide Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Dulaglutide Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Dulaglutide Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Dulaglutide Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dulaglutide Injection Industry Trends
  2. 2.2 Dulaglutide Injection Industry Drivers
  3. 2.3 Dulaglutide Injection Industry Opportunities and Challenges
  4. 2.4 Dulaglutide Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dulaglutide Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Dulaglutide Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Dulaglutide Injection Price (2021-2026)
  4. 3.4 Global Dulaglutide Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dulaglutide Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Dulaglutide Injection Company, Product Type & Application
  7. 3.7 Global Dulaglutide Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dulaglutide Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dulaglutide Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dulaglutide Injection Tier 1, Tier 2, and Tier 3
4 Dulaglutide Injection Regional Status and Outlook
  1. 4.1 Global Dulaglutide Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dulaglutide Injection Historic Market Size by Region
  3. 4.2.1 Global Dulaglutide Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dulaglutide Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dulaglutide Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dulaglutide Injection Forecasted Market Size by Region
  7. 4.3.1 Global Dulaglutide Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dulaglutide Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dulaglutide Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dulaglutide Injection by Application
  1. 5.1 Dulaglutide Injection Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Dulaglutide Injection Market Size by Application
  5. 5.2.1 Global Dulaglutide Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Dulaglutide Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Dulaglutide Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Dulaglutide Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Dulaglutide Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Dulaglutide Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Dulaglutide Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Dulaglutide Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly and Company
  2. 6.1.1 Eli Lilly and Company Company Information
  3. 6.1.2 Eli Lilly and Company Business Overview
  4. 6.1.3 Eli Lilly and Company Dulaglutide Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly and Company Dulaglutide Injection Product Portfolio
  6. 6.1.5 Eli Lilly and Company Recent Developments
  7. 6.2 Boan Biotech
  8. 6.2.1 Boan Biotech Company Information
  9. 6.2.2 Boan Biotech Business Overview
  10. 6.2.3 Boan Biotech Dulaglutide Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boan Biotech Dulaglutide Injection Product Portfolio
  12. 6.2.5 Boan Biotech Recent Developments
7 North America by Country
  1. 7.1 North America Dulaglutide Injection Sales by Country
  2. 7.1.1 North America Dulaglutide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dulaglutide Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Dulaglutide Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dulaglutide Injection Market Size by Country
  6. 7.2.1 North America Dulaglutide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dulaglutide Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Dulaglutide Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dulaglutide Injection Sales by Country
  2. 8.1.1 Europe Dulaglutide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dulaglutide Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Dulaglutide Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dulaglutide Injection Market Size by Country
  6. 8.2.1 Europe Dulaglutide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dulaglutide Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dulaglutide Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dulaglutide Injection Sales by Country
  2. 9.1.1 Asia-Pacific Dulaglutide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dulaglutide Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dulaglutide Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dulaglutide Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Dulaglutide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dulaglutide Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dulaglutide Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dulaglutide Injection Sales by Country
  2. 10.1.1 South America Dulaglutide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dulaglutide Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Dulaglutide Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dulaglutide Injection Market Size by Country
  6. 10.2.1 South America Dulaglutide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dulaglutide Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Dulaglutide Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dulaglutide Injection Sales by Country
  2. 11.1.1 Middle East and Africa Dulaglutide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dulaglutide Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dulaglutide Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dulaglutide Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Dulaglutide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dulaglutide Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dulaglutide Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dulaglutide Injection Value Chain Analysis
  2. 12.1.1 Dulaglutide Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dulaglutide Injection Production Mode & Process
  7. 12.2 Dulaglutide Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dulaglutide Injection Distributors
  10. 12.2.3 Dulaglutide Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst